Form 4: Achieve Life Sciences CEO John Bencich Acquires 5,000 Shares Through Employee Stock Purchase Plan
SEC Form 4 Filing
CEO John Bencich increased his holdings in Achieve Life Sciences by acquiring 5,000 shares of common stock through the company's Employee Stock Purchase Plan.
Summary
- On August 16, 2024, John Bencich, CEO of Achieve Life Sciences, acquired 5,000 shares of common stock.
- The shares were purchased at a price of $3.67 per share.
- This transaction was executed under the Issuer's 2017 Employee Stock Purchase Plan.
- Following the transaction, Bencich directly owns 100,636 shares of Achieve Life Sciences.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction, and the CEO's participation in the employee stock purchase plan is a mildly positive signal.
Positives
- The CEO's participation in the Employee Stock Purchase Plan could be seen as a positive signal, indicating confidence in the company's future.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives to participate in employee stock purchase plans.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment due to the CEO's increased investment in the company.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date of transaction: John Bencich acquired 5,000 shares of common stock. |
| 08/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.